Polycationic nanodrug covered with hyaluronic acid for treatment of P-glycoprotein overexpressing cancer cells

Biomacromolecules

Volumn 11, Issue 9, 2010, Pages 2387-2393

  Yim, Hyeona ^a   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALL-TRANS RETINOIC ACIDS; AVERAGE PARTICLE SIZE; CANCER CELLS; CANCER STEM CELLS; COLON CANCER; CYTOTOXIC; CYTOTOXIC MECHANISMS; DOXORUBICIN; FLUORESCENCE ACTIVATED CELL SORTING; HIGH CONCENTRATION; HYALURONIC ACIDS; MONITORING CHANGE; MULTIDRUG RESISTANCE; OVER-EXPRESSION; P-GLYCOPROTEIN; PHOSPHATE-BUFFERED SALINES; POLYETHYLENEIMINE; PROPIDIUM IODIDE;

CONFOCAL MICROSCOPY; GLYCOPROTEINS; OPTICAL MICROSCOPY; ORGANIC ACIDS; PARTICLE SIZE; POLYETHYLENES; STEM CELLS; TISSUE; ZETA POTENTIAL;

CYTOTOXICITY;

DOXORUBICIN; GLYCOPROTEIN P; HYALURONIC ACID; HYALURONIDASE; POLYCATION; POLYETHYLENEIMINE; PROPIDIUM IODIDE; RETINOIC ACID;

ARTICLE; CANCER CELL; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

APOPTOSIS; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; HYALURONIC ACID; NANOPARTICLES; P-GLYCOPROTEIN; POLYETHYLENEIMINE; POLYMERS; STOMACH NEOPLASMS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 77956516317     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm100562z     Document Type: Article

References (50)

1. Pauwels, E.; Erba, P.; Mariani, G.; Gomes, C. Multidrug resistance in cancer: its mechanism and its modulation Drug News Perspect. 2007, 20 (6) 371
2. Gottesman, M.; Fojo, T.; Bates, S. Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2002, 2 (1) 48-58
3. Cordon-Cardo, C.; Obrien, J.; Boccia, J.; Casals, D.; Bertino, J.; Melamed, M. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues J. Histochem. Cytochem. 1990, 38 (9) 1277
4. Figueredo, A.; Arnold, A.; Goodyear, M.; Findlay, B.; Neville, A.; Normandeau, R.; Jones, A. Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II study Ca-Cancer J. Clin. 65 (9) 1895-1902
5. Verweij, J.; Herweijer, H.; Oosterom, R.; Van der Burg, M.; Planting, A.; Seynaeve, C.; Stoter, G.; Nooter, K. A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance Br. J. Cancer 1991, 64 (2) 361
6. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 1981, 41 (5) 1967
7. Verdiere, A.; Dubernet, C.; Nemati, F.; Poupon, M.; Puisieux, F.; Couvreur, P. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells Cancer Chemother. Pharmacol. 1994, 33 (6) 504-508
8. Soma, C.; Dubernet, C.; Barratt, G.; Nemati, F.; Appel, M.; Benita, S.; Couvreur, P. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages Pharm. Res. 1999, 16 (11) 1710-1716
9. Mohajer, G.; Lee, E.; Bae, Y. Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells Pharm. Res. 2007, 24 (9) 1618-1627
10. Jabr-Milane, L.; van Vlerken, L.; Yadav, S.; Amiji, M. Multifunctional nanocarriers to overcome tumor drug resistance Cancer Treat. Rev. 2008, 34 (7) 592-602
11. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis Adv. Drug Delivery Rev. 2002, 54 (5) 631-651
12. Kukowska-Latallo, J.; Candido, K.; Cao, Z.; Nigavekar, S.; Majoros, I.; Thomas, T.; Balogh, L.; Khan, M.; Baker Jr, J. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 2005, 65 (12) 5317
13. Wong, H.; Bendayan, R.; Rauth, A.; Xue, H.; Babakhanian, K.; Wu, X. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system J. Pharmacol. Exp. Ther. 2006, 317 (3) 1372
14. Sera, T.; Shea, L. Materials for non-viral gene delivery: Biomaterials Annu. Rev. Mater. Sci. 2001, 31, 25-46
15. Hong, S.; Bielinska, A.; Mecke, A.; Keszler, B.; Beals, J.; Shi, X.; Balogh, L.; Orr, B.; Baker, J.; Banaszak Holl, M. Interaction of poly (amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport Bioconjugate Chem. 2004, 15 (4) 774-782
16. Moroson, H. Polycation-treated tumor cells in vivo and in vitro Cancer Res. 1971, 31 (3) 373
17. Park, K.; Kang, H.; Cho, J.; Chung, I.; Cho, S.; Bae, Y.; Na, K. All-trans-retinoic acid (ATRA)-grafted polymeric gene carriers for nuclear translocation and cell growth control Biomaterials 2009, 30 (13) 2642-2652
18. Franzmann, E.; Schroeder, G.; Goodwin, W.; Weed, D.; Fisher, P.; Lokeshwar, V. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors Int. J. Cancer 2003, 106 (3) 438-445
19. Lokeshwar, V.; Young, M.; Goudarzi, G.; Iida, N.; Yudin, A.; Cherr, G.; Selzer, M. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1 Cancer Res. 1999, 59 (17) 4464
20. Helander, I.; Latva-Kala, K.; Lounatmaa, K. Permeabilizing action of polyethyleneimine on Salmonella typhimurium involves disruption of the outer membrane and interactions with lipopolysaccharide Microbiology 1998, 144 (2) 385
21. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery J. Controlled Release 2006, 114 (1) 100-109
22. Kuo, J. Practical aspects of hyaluronan based medical products; CRC Press: New York, 2005.
23. Laurent, T. The chemistry, biology and medical applications of hyaluronan and its derivatives; Portland Press: London, 1998.
24. Liu, D.; Pearlman, E.; Diaconu, E.; Guo, K.; Mori, H.; Haqqi, T.; Markowitz, S.; Willson, J.; Sy, M. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (15) 7832
25. Lokeshwar, V.; Rubinowicz, D.; Schroeder, G.; Forgacs, E.; Minna, J.; Block, N.; Nadji, M.; Lokeshwar, B. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer J. Biol. Chem. 2001, 276 (15) 11922
26. Home, C. Hyaluronidase as a therapeutic target in cancer: a matter of too little or too much.
27. Lokeshwar, V.; Lokeshwar, B.; Pham, H.; Block, N. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression Cancer Res. 1996, 56 (3) 651
28. Yim, H.; Jo, E.; Na, K. Development of a new micellar anticancer drug: cationic polymer/vitamin A conjugate covered with hyaluronic acid Macromol. Res. 2010
29. Zacherl, J.; Hamilton, G.; Thalhammer, T.; Riegler, M.; Cosentini, E.; Ellinger, A.; Bischof, G.; Schweitzer, M.; Teleky, B.; Koperna, T. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH Cancer Chemother. Pharmacol. 1994, 34 (2) 125-132
30. Hunter, J.; Hirst, B.; Simmons, N. Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein Br. J. Cancer 1991, 64 (3) 437
31. Lee, T.; Park, J.; Min, Y.; Kim, K.; Choi, C. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy BMC Gastroenterol. 2008, 8 (1) 33
32. Bidwell, G., III.; Fokt, I.; Priebe, W.; Raucher, D. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin Biochem. Pharmacol. 2007, 73 (5) 620-631
33. Umebayashi, Y.; Miyamoto, Y.; Wakita, M.; Kobayashi, A.; Nishisaka, T. Elevation of plasma membrane permeability on laser irradiation of extracellular latex particles J. Biochem. 2003, 134 (2) 219
34. Ha, H.; Snyder, S. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (24) 13978
35. Krysko, D.; Vanden Berghe, T.; DHerde, K.; Vandenabeele, P. Apoptosis and necrosis: detection, discrimination and phagocytosis Methods 2008, 44 (3) 205-221
36. Drabløs, F.; Feyzi, E.; Aas, P.; Vaagbø, C.; Kavli, B.; Bratlie, M.; Pena-Diaz, J.; Otterlei, M.; Slupphaug, G.; Krokan, H. Alkylation damage in DNA and RNA-repair mechanisms and medical significance DNA Repair 2004, 3 (11) 1389-1407
37. Manfredi, J.; Horwitz, S. Taxol: an antimitotic agent with a new mechanism of action Pharmacol. Ther. 1984, 25 (1) 83
38. Hong, S.; Leroueil, P.; Janus, E.; Peters, J.; Kober, M.; Islam, M.; Orr, B.; Baker, J., Jr.; Holl, M. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability Bioconjugate Chem. 2006, 17 (3) 728-734
39. Mecke, A.; Lee, D.; Ramamoorthy, A.; Orr, B.; Holl, M. Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers Langmuir 2005, 21 (19) 8588-8590
40. Davis, M. Non-viral gene delivery systems Curr. Opin. Biotechnol. 2002, 13 (2) 128-131
41. Rich, D.; Singh, J. The carbodiimide method. The Peptides: Major methods of peptide bond formation; 1979; p 241.
42. Bouyer, F.; Robben, A.; Yu, W.; Borkovec, M. Aggregation of colloidal particles in the presence of oppositely charged polyelectrolytes: effect of surface charge heterogeneities Langmuir 2001, 17 (17) 5225-5231
43. Chen, C.; Chin, J.; Ueda, K.; Clark, D.; Pastan, I.; Gottesman, M.; Roninson, I. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 1986, 47 (3) 381-389
44. Lee, T.; Park, J.; Min, Y.; Kim, K.; Choi, C. Epigenetic mechanisms involved in differential MDR 1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy BMC Gastroenterol. 2008, 8 (1) 33
45. Pham, H.; Block, N.; Lokeshwar, V. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer Cancer Res. 1997, 57 (4) 778
46. Culty, M.; Miyake, K.; Kincade, P.; Silorski, E.; Butcher, E.; Underhill, C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins J. Cell Biol. 1990, 111 (6) 2765-2774
47. Rai, S.; Duh, F.; Vigdorovich, V.; Danilkovitch-Miagkova, A.; Lerman, M.; Miller, A. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (8) 4443
48. Hua, Q.; Knudson, C.; Knudson, W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis J. Cell Sci. 1993, 106 (1) 365
49. 13C 1-D and 2-D NMR Polym. Int. 2006, 55 (9) 1040-1048
50. Kang, H.; Lee, M.; Bae, Y. Polymeric gene carriers Crit. Rev. Eukaryotic Gene Expression 2005, 15 (4) 317